Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Federal Trade Commission
Cerilliant
Fuji
Julphar
Mallinckrodt
Colorcon
US Army

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020525

« Back to Dashboard

NDA 020525 describes GYNE-LOTRIMIN 3, which is a drug marketed by Bayer Healthcare Llc and is included in three NDAs. Additional details are available on the GYNE-LOTRIMIN 3 profile page.

The generic ingredient in GYNE-LOTRIMIN 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 020525
Tradename:GYNE-LOTRIMIN 3
Applicant:Bayer Healthcare Llc
Ingredient:clotrimazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020525

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;VAGINALStrength200MG
Approval Date:Jul 29, 1996TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fish and Richardson
Farmers Insurance
Moodys
Merck
McKinsey
AstraZeneca
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.